Bruker Corporation - 6.375% Man (BRKRP): Financials
Trailing 12 months ended June 30, 2026
Income statement, cash flow and balance sheet figures for Bruker Corporation - 6.375% Man (BRKRP), read directly from the XBRL data the company files with the SEC. Over the trailing twelve months the company reported $3.5B of revenue, up 1.6% year over year. Net loss was $71.2M, or $-0.70 per diluted share. Free cash flow was $93.9M. Gross margin stood at 46.4%.
15 fiscal years of history are available, back to 2011.
Frequently asked questions
How much revenue does BRKRP make?
Bruker Corporation - 6.375% Man reported $3.5B of revenue over the trailing twelve months, for the period ended June 30, 2026. That is up 1.6% from the same period a year earlier.
Is BRKRP profitable?
Bruker Corporation - 6.375% Man was unprofitable over the trailing twelve months, with a net loss of $71.2M.
Where does this financial data come from?
Every figure on this page is read from the company's own SEC 10-Q and 10-K filings. Nothing is estimated by a third party. Quarterly figures a company does not file separately (most commonly the fourth quarter) are derived by subtracting the reported year-to-date quarters from the full fiscal year, and are labelled as derived.
What is the difference between quarterly, annual and TTM?
Quarterly shows each three-month fiscal period on its own. Annual shows the full fiscal year as filed in the 10-K. TTM (trailing twelve months) sums the last four reported quarters, which is the most current annualised view between 10-K filings.